Volitionrx (VNRX) Accounts Payables (2011 - 2025)

Volitionrx's Accounts Payables history runs 11 years deep, the most recent figure standing at $2.9 million for Q4 2025.

• Quarterly Accounts Payables rose 5.52% year-over-year to $2.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.9 million (up 5.52% YoY) and the FY2025 annual result came in at $2.9 million, up 5.52% from the prior year.
• Accounts Payables was $2.9 million for Q4 2025 at Volitionrx, down from $3.1 million in the prior quarter.
• Across five years, Accounts Payables topped out at $3.5 million in Q1 2024 and bottomed at $1.1 million in Q2 2021.
• A 5-year average of $2.7 million and a median of $2.9 million in 2025 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2022 — Accounts Payables jumped 140.24% — and 2025, when it retreated 29.78%.
• Volitionrx's Accounts Payables stood at $1.5 million in 2021, then surged by 97.28% to $3.0 million in 2022, then advanced by 5.53% to $3.2 million in 2023, then dropped by 13.86% to $2.8 million in 2024, then rose by 5.52% to $2.9 million in 2025.
• Business Quant data shows VNRX's Accounts Payables at $2.9 million in Q4 2025, $3.1 million in Q3 2025, and $2.4 million in Q2 2025.